NEW YORK (GenomeWeb News) – Abbott reported this morning that its first-quarter molecular diagnostics sales increased around 1 percent year over year, while its overall diagnostics revenues climbed a little more than 4 percent.

The pharmaceuticals, diagnostics, and medical devices firm had total revenues of $5.38 billion, up 2 percent from $5.28 billion for the first quarter of 2012. Sales for its diagnostics business, overall, were $1.09 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.